Herrlinger U - Search Results

1

The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma.

Schaub C, Schäfer N, Mack F, Stuplich M, Kebir S, Niessen M, Tzaridis T, Banat M, Vatter H, Waha A, Herrlinger U, Glas M. Schaub C, et al. Among authors: herrlinger u. J Cancer Res Clin Oncol. 2016 Aug;142(8):1825-9. doi: 10.1007/s00432-016-2187-3. Epub 2016 Jun 18. J Cancer Res Clin Oncol. 2016. PMID: 27318492

2

Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.

Herrlinger U, Schabet M, Brugger W, Kortmann RD, Kanz L, Bamberg M, Dichgans J, Weller M. Herrlinger U, et al. Cancer. 2001 Jan 1;91(1):130-5. doi: 10.1002/1097-0142(20010101)91:1<130::aid-cncr17>3.0.co;2-8. Cancer. 2001. PMID: 11148569

3

Treosulfan chemotherapy for recurrent malignant glioma.

Schmidt F, Wick W, Herrlinger U, Dichgans J, Weller M. Schmidt F, et al. Among authors: herrlinger u. J Neurooncol. 2000 Sep;49(3):231-4. doi: 10.1023/a:1006496831144. J Neurooncol. 2000. PMID: 11212902 Clinical Trial.

4

UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma.

Herrlinger U, Rieger J, Steinbach JP, Nägele T, Dichgans J, Weller M. Herrlinger U, et al. J Neurooncol. 2005 Feb;71(3):295-9. doi: 10.1007/s11060-004-1726-y. J Neurooncol. 2005. PMID: 15735920 Clinical Trial.

5

PCV chemotherapy for recurrent glioblastoma.

Schmidt F, Fischer J, Herrlinger U, Dietz K, Dichgans J, Weller M. Schmidt F, et al. Among authors: herrlinger u. Neurology. 2006 Feb 28;66(4):587-9. doi: 10.1212/01.wnl.0000197792.73656.c2. Neurology. 2006. PMID: 16505319 Clinical Trial.

6

Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.

Herrlinger U, Rieger J, Koch D, Loeser S, Blaschke B, Kortmann RD, Steinbach JP, Hundsberger T, Wick W, Meyermann R, Tan TC, Sommer C, Bamberg M, Reifenberger G, Weller M. Herrlinger U, et al. J Clin Oncol. 2006 Sep 20;24(27):4412-7. doi: 10.1200/JCO.2006.06.9104. J Clin Oncol. 2006. PMID: 16983109 Clinical Trial.

7

Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.

Wick A, Felsberg J, Steinbach JP, Herrlinger U, Platten M, Blaschke B, Meyermann R, Reifenberger G, Weller M, Wick W. Wick A, et al. Among authors: herrlinger u. J Clin Oncol. 2007 Aug 1;25(22):3357-61. doi: 10.1200/JCO.2007.10.7722. J Clin Oncol. 2007. PMID: 17664483 Clinical Trial.

8

Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma.

Glas M, Hennemann B, Hirschmann B, Marienhagen J, Schmidt-Wolf I, Herrlinger U, Bogdahn U, Hau P. Glas M, et al. Among authors: herrlinger u. Acta Oncol. 2008;47(3):479-80. doi: 10.1080/02841860701678795. Epub 2007 Oct 12. Acta Oncol. 2008. PMID: 17934891 No abstract available.

9

Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series.

Glas M, Koch H, Hirschmann B, Jauch T, Steinbrecher A, Herrlinger U, Bogdahn U, Hau P. Glas M, et al. Among authors: herrlinger u. Oncology. 2007;72(5-6):302-7. doi: 10.1159/000113052. Epub 2008 Jan 14. Oncology. 2007. PMID: 18198491

10

Liposomal cytarabine given concomitantly with radiotherapy in a patient with leptomeningeal metastasis from breast cancer.

Glas M, Stuplich M, Tschampa H, Urbach H, Rasch K, Herrlinger U. Glas M, et al. Among authors: herrlinger u. J Neurol. 2008 Nov;255(11):1838-9. doi: 10.1007/s00415-008-0014-8. Epub 2008 Jul 25. J Neurol. 2008. PMID: 18661166 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters